HPV legislation in Massachusetts

Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 6,437,193

Incidence & Mortality (2008 Score / 2007 Score)
 * Cervical Cancer Incidence Rate: 5.2/100,000 (2 / 2)
 * Cervical Cancer Incidence Rate/Race: White: 5.1, Black: 8.2, Hispanic: 13.6, Asian/Pacific Islander: 7.9
 * Cervical Cancer Mortality Rate: 3.0/100,000 (2 / 2)
 * Cervical Cancer Mortality Rate/Race: White: 1.7, Black: 2.5

Screening (2008 Score / 2007 Score)
 * Cervical Cancer Screening Rate: 87.7% (2 / 2)
 * Cervical Cancer Screening Rate/Race: White: 88.4%, Black: 92.9%, Hispanic: 79.9%, Asian/Pacific Islander: 81.4%
 * % Uninsured/Unscreened: 23.9% (1 / 1)
 * Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)
 * Rate Uninsured Women: 12% (1 / 1)
 * % Low Income/Uninsured Women: 25%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 2)
 * There are no new screening requirements.

Task Forces (0 / 2)
 * There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)
 * SB 102 would require 6th grade girls to receive the HPV vaccine; in committee.

HPV Vaccine Information Programs (0 / 0)
 * There is no HPV vaccine information activity.

Miscellaneous (0 / 0)
 * There is no new miscellaneous cervical cancer prevention activity.

Additional Notes
 * Gov. Deval Patrick requested $72 million in additional public health spending for 2008, including $24.8 million for the state’s universal immunization program to provide an estimated 72,000 girls between the ages of 9–18 with the HPV vaccine.

Annual Ratings
 * 2008: Very Good (15 out of 22 points)
 * 2007: Very Good (12 out of 18 points)

SourceWatch Resources

 * Gardasil
 * GlaxoSmithKline
 * Merck
 * Women in Government
 * Edelman
 * The Marketing of Gardasil in Australia
 * The Marketing of Gardasil in Canada
 * The Marketing of Gardasil in Europe
 * The Marketing of Gardasil in New Zealand
 * The Marketing of Gardasil in the United States
 * Direct-to-consumer advertising
 * Disease Mongering
 * Drug industry